Literature DB >> 24075302

Association between renal replacement therapy in critically ill patients with severe acute kidney injury and mortality.

Sean M Bagshaw1, Shigehiko Uchino, John A Kellum, Hiroshi Morimatsu, Stanislao Morgera, Miet Schetz, Ian Tan, Catherine Bouman, Etienne Macedo, Noel Gibney, Ashita Tolwani, Heleen M Oudemans-van Straaten, Claudio Ronco, Rinaldo Bellomo.   

Abstract

PURPOSE: To evaluate the characteristics and outcomes of critically ill patients with severe acute kidney injury (AKI) treated and not treated with renal replacement therapy (RRT).
METHODS: Secondary analysis of a multi-centre cohort study. Primary exposure was RRT. Primary outcome was propensity and multi-variable adjusted-hospital mortality.
RESULTS: We studied 1250 patients (71.3%) who received and 502 (28.7%) who did not receive RRT. Reasons for not starting RRT (not mutually exclusive) were limitations of support (33.6%, n = 169), adequate urine output (46.2%; n = 232), plan to observe (56.4%; n = 283), and advanced age (12.6%; n = 63). Mortality was higher in those not receiving RRT due to limitations and advanced age but lower for adequate urine output and plan to observe. Propensity and multi-variable adjusted analysis showed no statistical difference in hospital mortality (adj-OR 1.47; 95% CI, 0.93-2.24) in patients receiving RRT. Results were similar in a sensitivity analysis restricted to patients fulfilling risk, injury, failure, loss, end-stage kidney disease-FAILURE criteria (37.0%; n = 446) (adj-OR 1.36; 95% CI, 0.70-2.66).
CONCLUSION: In this cohort, reasons for not starting RRT included limitations of support and perception of impending renal recovery. Despite similar risk of mortality after adjusting for selection bias and confounders, RRT-treated patients were fundamentally different from non-treated patients across a spectrum of variables that precludes valid comparison in observational data.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Critical illness; Length of stay; Mortality; RIFLE criteria; Renal recovery; Renal replacement therapy

Mesh:

Substances:

Year:  2013        PMID: 24075302     DOI: 10.1016/j.jcrc.2013.08.002

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  14 in total

Review 1.  Utility of Electronic Medical Record Alerts to Prevent Drug Nephrotoxicity.

Authors:  Melissa Martin; F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

2.  IDEAL-ICU in Context.

Authors:  David E Leaf; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-17       Impact factor: 8.237

3.  Selection and Receipt of Kidney Replacement in Critically Ill Older Patients with AKI.

Authors:  Sean M Bagshaw; Neill K J Adhikari; Karen E A Burns; Jan O Friedrich; Josée Bouchard; Francois Lamontagne; Lauralyn A McIntrye; Jean-François Cailhier; Peter Dodek; Henry T Stelfox; Margaret Herridge; Stephen Lapinsky; John Muscedere; James Barton; Donald Griesdale; Mark Soth; Althea Ambosta; Gerald Lebovic; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-21       Impact factor: 8.237

4.  Our paper 20 years later: from acute renal failure to acute kidney injury--the metamorphosis of a syndrome.

Authors:  Wilfred Druml; Kurt Lenz; Anton N Laggner
Journal:  Intensive Care Med       Date:  2015-08-22       Impact factor: 17.440

5.  A policy of preemption: the timing of renal replacement therapy in AKI.

Authors:  F Perry Wilson
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-08       Impact factor: 8.237

Review 6.  Acute kidney injury-epidemiology, outcomes and economics.

Authors:  Oleksa Rewa; Sean M Bagshaw
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

7.  Hospital Variation in Renal Replacement Therapy for Sepsis in the United States.

Authors:  Thomas S Valley; Brahmajee K Nallamothu; Michael Heung; Theodore J Iwashyna; Colin R Cooke
Journal:  Crit Care Med       Date:  2018-02       Impact factor: 7.598

8.  Can this patient be safely weaned from RRT?

Authors:  Kada Klouche; R T Noel Gibney; Lui G Forni
Journal:  Intensive Care Med       Date:  2017-10-20       Impact factor: 17.440

9.  Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial.

Authors:  Gordon S Doig; Fiona Simpson; Rinaldo Bellomo; Philippa T Heighes; Elizabeth A Sweetman; Douglas Chesher; Carol Pollock; Andrew Davies; John Botha; Peter Harrigan; Michael C Reade
Journal:  Intensive Care Med       Date:  2015-04-30       Impact factor: 17.440

10.  AKI complications in critically ill patients: association with mortality rates and RRT.

Authors:  Alexandre Braga Libório; Tacyano Tavares Leite; Fernanda Macedo de Oliveira Neves; Flávio Teles; Candice Torres de Melo Bezerra
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-05       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.